The Specificity of the FOXL2 c.402C>G Somatic Mutation: A Survey of Solid Tumors

• Kasmintan A. Schrader ,

  Contributed equally to this work with: Kasmintan A. Schrader, Bella Gorbatcheva

  Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Bella Gorbatcheva ,

  Contributed equally to this work with: Kasmintan A. Schrader, Bella Gorbatcheva

  Affiliation Novartis Institute for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Janine Senz,

  Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Alireza Heravi-Moussavi,

  Affiliation Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Nataliya Melnyk,

  Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Clara Salamanca,

  Affiliation Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Sarah Maines-Bandiera,

  Affiliation Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Susanna L. Cooke,

  Affiliation Cancer Research, Cambridge Research Institute, Cambridge, United Kingdom

  ⨯
• Peter Leung,

  Affiliation Department of Obstetrics and Gynecology, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada

  ⨯
• James D. Brenton,

  Affiliation Cancer Research, Cambridge Research Institute, Cambridge, United Kingdom

  ⨯
• C. Blake Gilks,

  Affiliation Genetic Pathology and Evaluation Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada

  ⨯
• John Monahan,

  Affiliation Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• David G. Huntsman

  * E-mail: dhuntsma@bccancer.bc.ca

  Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Novartis Institute for Biomedical Research, Cambridge, Massachusetts, United States of America, Genetic Pathology and Evaluation Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada

  ⨯